GPCR vs RXRX

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 10, 2026

GPCR

42.2
AI Score
VS
RXRX Wins

RXRX

55.9
AI Score

Investment Advisor Scores

GPCR

42score
Recommendation
HOLD

RXRX

56score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric GPCR RXRX Winner
Forward P/E 0 0 Tie
PEG Ratio 0 0 Tie
Revenue Growth 0.0% -60.1% GPCR
Earnings Growth 0.0% 0.0% Tie
Tradestie Score 42.2/100 55.9/100 RXRX
Profit Margin 0.0% 0.0% Tie
Beta 1.00 1.00 Tie
AI Recommendation HOLD HOLD Tie

Relative Price Performance (Last 90 Days)

GPCR 1M: -38.5% · 3M: -45.8% RXRX 1M: +22.2% · 3M: +7.1%

Current Technical Phase

GPCR

Markdown
Sell / avoid

Price below a falling SMA50 (slope -11.0%), weak momentum, RSI 18

RSI (14): 18.3 · Price: $28.98

RXRX

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (2.4% over 20 days), RSI 61

RSI (14): 61.0 · Price: $4.07

Fundamentals Snapshot

Metric GPCR RXRX
Market Cap — —
Forward P/E -13.3 -4.5
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth 0.0% -0.6%
Gross Margin — -7.2%
Operating Margin 0.0% -17.6%
EPS -3.03 -1.02
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, RXRX is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.